SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006256
Filing Date
2021-05-06
Accepted
2021-05-06 16:30:39
Documents
71
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q knsa-20210331x10q.htm   iXBRL 10-Q 1932284
2 EX-10.1 knsa-20210331xex10d1.htm EX-10.1 193599
3 EX-10.2 knsa-20210331xex10d2.htm EX-10.2 38014
4 EX-10.3 knsa-20210331xex10d3.htm EX-10.3 95478
5 EX-10.4 knsa-20210331xex10d4.htm EX-10.4 22060
6 EX-31.1 knsa-20210331xex31d1.htm EX-31.1 11326
7 EX-31.2 knsa-20210331xex31d2.htm EX-31.2 10482
8 EX-32.1 knsa-20210331xex32d1.htm EX-32.1 6289
9 EX-32.2 knsa-20210331xex32d2.htm EX-32.2 6263
10 GRAPHIC knsa-20210331xex10d1002.jpg GRAPHIC 51476
  Complete submission text file 0001558370-21-006256.txt   7379426

Data Files

Seq Description Document Type Size
11 EX-101.SCH knsa-20210331.xsd EX-101.SCH 48825
12 EX-101.CAL knsa-20210331_cal.xml EX-101.CAL 39643
13 EX-101.DEF knsa-20210331_def.xml EX-101.DEF 206525
14 EX-101.LAB knsa-20210331_lab.xml EX-101.LAB 466080
15 EX-101.PRE knsa-20210331_pre.xml EX-101.PRE 347798
16 EXTRACTED XBRL INSTANCE DOCUMENT knsa-20210331x10q_htm.xml XML 1040832
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38492 | Film No.: 21898322
SIC: 2834 Pharmaceutical Preparations